American Association for Cancer Research
Obesity linked to worse outcomes in early breast cancer treatment
Obesity is associated with worse outcomes overall in early-stage breast cancer, researchers reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011. Obesity was linked to shorter time to recurrence (TT…
MRI may be noninvasive method to measure breast cancer prognosis
Quantitative magnetic resonance imaging measures were associated with prognostic tumor markers, demonstrating the potential of magnetic resonance imaging for prediction of disease prognosis and stratification of patients to appropriate…
Addition of trastuzumab may potentially equalize disease-free survival outcomes among obese and normal-weight patients
SAN ANTONIO — A large, multicenter, randomized study has shown that obese patients with HER2-positive breast cancer have larger tumors, increased lymph node involvement and, when not treated with trastuzumab, poorer long-term outcomes than normal-we…
Addition of bevacizumab to conventional therapy improved progression-free survival in HER2-positive breast cancer
SAN ANTONIO — Data evaluated by an independent review committee revealed that the addition of bevacizumab to trastuzumab and docetaxel significantly improved progression-free survival in HER2-positive breast cancer, despite findings from an investig…
Moffitt Cancer Center researchers find MK1775 active against sarcomas
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla. Their findings, recently appearing in Molecular Cancer …
Racial disparities still exist in colorectal cancer screening despite increased Medicare coverage
PHILADELPHIA — Despite expanded Medicare coverage for colorectal cancer screening tests, lower rates still exist among blacks and Hispanics compared to other ethnic groups, according to research published in Cancer, Epidemiology, Biomarkers & Pre…